x
|
ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF
1934
|
New
York
|
13-5651322
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
1115
Broadway, New York, New York
|
10010
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Title
of each class
|
Name
of each exchange on which registered
|
|
Common
Stock, $.01 par value
|
NYSE
Amex
|
|
Large
accelerated filer ¨
|
Accelerated
filer ¨
|
Non-accelerated
filer ¨
|
Smaller
reporting company x
|
(do
not check if a smaller reporting
company)
|
PART
III
|
1
|
ITEM
10. – DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE
GOVERNANCE
|
1
|
ITEM
11. – EXECUTIVE COMPENSATION
|
4
|
ITEM
12. – SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
14
|
ITEM
13. – CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
|
18
|
ITEM
14. – PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
19
|
PART
IV
|
19
|
ITEM
15. – EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
19
|
Name
|
Age
|
Position
|
||
Thomas
J. Lynch
|
42
|
Chairman
and Chief Executive Officer
|
||
Linda
LoRe
|
56
|
President
and Director
|
||
Peter
Cole(2)
|
62
|
Director
|
||
John
L. Eisel(1)(2)(3)
|
61
|
Director
|
||
William
F. Harley(2)(3)
|
47
|
Director
|
||
Milton
J. Walters(1)(3)
|
68
|
Director
|
Name and
Principal
Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards
($)(1)
|
All Other
Compensation
($)
|
Total ($)
|
|||||||||||||||||||
Thomas
J. Lynch
|
2010
|
597,692 | (2) | - | 24,221 | (3) | 43,419 | 28,317 | (4) | 693,649 | ||||||||||||||||
Chairman
and CEO
|
2009
|
336,923 | (5) | - | 9,913 | (3) | 46,323 | 14,514 | (6) | 407,673 | ||||||||||||||||
Linda
LoRe
|
2010
|
650,000 | - | 156,531 | (7) | 144,652 | 39,282 | (4) | 990,465 | |||||||||||||||||
President
|
2009
|
650,000 | - | 247,399 |
(7)
|
144,652 | 41,088 |
(6)
|
1,083,139 | |||||||||||||||||
Thomas
Rende
|
2010
|
336,077 | (8) | - | 7,583 | (9) | 47,198 | 20,324 | (4) | 411,182 | ||||||||||||||||
EVP
and CFO
|
2009
|
340,000 | - | - | 51,523 | 24,492 | (6) | 416,015 |
(1)
|
Represents
the dollar amount recognized for financial statement reporting purposes
during the years ended July 31, 2010 and July 25, 2009, computed in
accordance with the Financial Accounting Standards Board’s Accounting
Standards Codification Topic 718 (“ASC 718”), except that, pursuant to the
rules of the SEC relating to executive compensation disclosure, the
amounts exclude the impact of estimated forfeitures related to
service-based vesting conditions. Assumptions used in the
calculation of these amounts are disclosed in Note 12 to our audited
consolidated financial statements for the year ended July 31, 2010
contained in our Annual Report on Form 10-K filed with the SEC on October
25, 2010.
|
(2)
|
Mr.
Lynch’s annual base salary decreased from $600,000 to $540,000 effective
June 29, 2010 pursuant to his amended and restated employment
agreement dated June 29, 2010.
|
(3)
|
Represents
stock-based compensation expense, as computed in accordance with ASC 718,
recorded during the years ended July 31, 2010 and July 25, 2009
relating to 150,000 shares of restricted stock issued to Mr. Lynch on June
29, 2010, which vest in three equal annual installments of 50,000 shares
on each of January 2, 2012, 2013 and 2014 provided he is employed by us on
each such date, and 100,000 shares of restricted stock issued to Mr. Lynch
on January 29, 2009 under our 2000 Performance Equity Plan, 50,000 shares
of which vested on January 2, 2010 and 50,000 shares of which vest on
January 2, 2011 provided he is employed by us on such
date.
|
(4)
|
Represents
payments that we made in fiscal year 2010 for the named executive officers
as follows:
|
Named
Executive Officer
|
Life
Insurance ($)
|
Long Term
Disability
Insurance ($)
|
Group
Health
Insurance ($)
|
Automobile
Expenses ($)
|
Matching
Contribution
Under the
401(k) Plan ($)
|
Total ($)
|
||||||||||||||||||
Thomas
J. Lynch
|
- | 1,037 | 12,280 | 15,000 | - | 28,317 | ||||||||||||||||||
Linda
LoRe
|
10,550 | 1,728 | 12,004 | 15,000 | - | 39,282 | ||||||||||||||||||
Thomas
Rende
|
2,680 | 864 | 12,280 | 4,500 | - | 20,324 |
(5)
|
Represents
salary paid to Mr. Lynch in accordance with the terms of his employment
agreement dated January 29, 2009 from the commencement of his employment
on January 2, 2009 to July 25,
2009.
|
(6)
|
Represents
payments that we made in fiscal year 2009 for the named executive officers
as follows:
|
Named
Executive Officer
|
Life
Insurance ($)
|
Long Term
Disability
Insurance ($)
|
Group
Health
Insurance ($)
|
Automobile
Expenses ($)
|
Matching
Contribution
Under the
401(k) Plan ($)
|
Total ($)
|
||||||||||||||||||
Thomas
J. Lynch
|
- | 313 | 5,451 | 8,750 | - | 14,514 | ||||||||||||||||||
Linda
LoRe
|
10,550 | 1,070 | 11,843 | 15,000 | 2,625 | 41,088 | ||||||||||||||||||
Thomas
Rende
|
2,680 | 992 | 16,920 | 3,900 | - | 24,492 |
(7)
|
Represents
stock-based compensation expense, as computed in accordance with ASC 718,
recorded during the years ended July 31, 2010 and July 25, 2009 relating
to 200,000 shares of restricted stock issued to Ms. LoRe on January 28,
2008. 100,000 shares vested on December 31, 2009, and 50,000
shares vest on each of December 31, 2010 and 2011 provided she is employed
by us on each such date.
|
(8)
|
In
accordance with Mr. Rende’s amended and restated employment agreement
dated June 1, 2010, his annual base salary decreased from $340,000 to
$310,000 effective June 1,
2010.
|
(9)
|
Represents
stock-based compensation expense, as computed in accordance with ASC 718,
recorded during the year ended July 31, 2010 relating to 100,000 shares of
restricted stock issued to Mr. Rende on June 1, 2010 under our 2000
Performance Equity Plan. 25,000 shares vest on each of June 1,
2011 and 2012, and the remaining 50,000 shares vest on June 1, 2013,
provided Mr. Rende is employed by us on each such
date.
|
Name
|
Grant
Date
|
Number of
Shares of
Stock
(#)
|
Number of
Securities
Underlying
Options (#)
|
Exercise or
Base Price
of Option
Awards
($/sh)
|
Exercise Price
of Option
Awards on the
Grant Date
($/sh)(1)
|
Grant Date
Fair Value of
Stock and
Option
Awards ($)(2)
|
||||||||||||||||
Thomas
J. Lynch
|
6/29/10
|
150,000 | (3) | - | - | - | 117,000 | |||||||||||||||
6/29/10
|
- | 600,000 | (4) | 0.78 | 0.78 | 333,746 | ||||||||||||||||
Thomas
Rende
|
6/01/10
|
100,000 | (5) | - | - | - | 84,000 | |||||||||||||||
6/01/10
|
- | 100,000 | (6) | 0.84 | 0.84 | 60,060 |
(1)
|
Represents
the closing price of our common stock on the date of
grant.
|
(2)
|
The
fair value of the option awards was calculated using the Black-Scholes
option-pricing model with the following weighted-average assumptions used
for each grant: risk-free interest rate 2.55%; expected life of 7 years;
expected volatility 76.2% and expected dividends of zero. The
fair value generated by the Black-Scholes model may not be indicative of
the future benefit, if any, that may be received by the
holder. The fair value of the stock awards was calculated by
the fair value of our common stock on the date of grant multiplied by the
respective number of shares.
|
(3)
|
Represents
shares of restricted stock issued to Mr. Lynch in accordance with the
terms of his employment agreement dated June 29, 2010. The
shares vest in equal annual installments of 50,000 shares on each of
January 2, 2012, 2013 and 2014, provided that he is employed by us on each
such date.
|
(4)
|
Represents
shares issuable upon exercise of a stock option granted to Mr. Lynch in
accordance with the terms of his employment agreement dated June 29,
2010. 150,000 shares vest on January 2, 2012, 200,000 shares
vest on January 2, 2013 and the remaining 250,000 shares vest on January
2, 2014.
|
(5)
|
Represents
shares of restricted stock issued to Mr. Rende in accordance with the
terms of his employment agreement dated June 1, 2010. 25,000
shares vest on each of June 1, 2011 and 2012, and the remaining 50,000
shares vest on June 1, 2013, provided that he is employed by us on each
such date.
|
(6)
|
Represents
shares issuable upon exercise of a stock option granted to Mr. Rende in
accordance with the terms of his employment agreement dated June 1,
2010. 25,000 shares vest on each of June 1, 2011 and 2012 and
the remaining 50,000 shares vest on June 1,
2013.
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||
Name
|
Number
of
Securities
Underlying
Unexercised
Exercisable
Options
(#)
|
Number
of
Securities
Underlying
Unexercised
Un-exercisable
Options
(#)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number
of
Shares
that have
Not
Vested (#)
|
Market
Value of
Shares
that have
Not
Vested ($)
|
|||||||||||||||
Thomas
J. Lynch
|
240,000 | 120,000 | (1) | 0.38 |
1/28/2019
|
50,000 | (7) | 46,000 | (11) | ||||||||||||
600,000 | (2) | 0.78 |
6/28/2020
|
150,000 | (8) | 138,000 | (11) | ||||||||||||||
Linda
LoRe
|
244,907 | - | 1.90 |
12/1/2013
|
100,000 | (9) | 92,000 | (11) | |||||||||||||
180,342 | 60,113 | (3) | 2.46 |
12/7/2016
|
|||||||||||||||||
75,000 | 25,000 | (4) | 3.10 |
1/27/2018
|
|||||||||||||||||
Thomas
Rende
|
37,500 | - | 2.90 |
12/9/2014
|
100,000 | (10) | 92,000 | (11) | |||||||||||||
45,000 | 30,000 | (5) | 2.00 |
10/12/2016
|
|||||||||||||||||
78,750 | - | 3.10 |
1/27/2015
|
||||||||||||||||||
- | 100,000 | (6) | 0.84 |
5/31/2020
|
(1)
|
These
options vest on January 2, 2011.
|
(2)
|
These
options vest in three annual installments as follows: (i) 150,000 options
vest on January 2, 2012, (ii) 200,000 options vest on January 2, 2013 and
(iii) 250,000 options vest on January 2,
2014.
|
(3)
|
These
options vest on January 29, 2011.
|
(4)
|
These
options vest on January 28, 2011.
|
(5)
|
These
options vest in two equal annual installments beginning on October 13,
2010.
|
(6)
|
These
options vest in three annual installments as follows: (i) 25,000 options
vest on June 1, 2011, (ii) 25,000 options vest on June 1, 2012 and (iii)
50,000 options vest on June 1,
2013.
|
(7)
|
Represents
shares of restricted stock issued to Mr. Lynch in accordance with the
terms of his employment agreement dated January 29, 2009. The
shares vest on January 2, 2011, provided Mr. Lynch is employed by us on
such date.
|
(8)
|
Represents
shares of restricted stock issued to Mr. Lynch in accordance with the
terms of his employment agreement dated June 29, 2010. The
shares vest in equal annual installments of 50,000 shares on each of
January 2, 2012, 2013 and 2014, provided Mr. Lynch is employed by us on
each such date.
|
(9)
|
Represents
shares of restricted stock issued to Ms. LoRe in January 2008 in
accordance with the terms of an equity incentive agreement, dated December
14, 2007. The shares vest in equal annual installments of
50,000 shares on each of December 31, 2010 and 2011, provided Ms. LoRe is
employed by us on each such date.
|
(10)
|
Represents
shares of restricted stock issued to Mr. Rende in accordance with the
terms of his employment agreement dated June 1, 2010. 25,000
shares vest on each of June 1, 2011 and 2012, and the remaining 50,000
shares vest on June 1, 2013, provided Mr. Rende is employed by us on each
such date.
|
(11)
|
The
market value of shares reported is computed based on the July 30,
2010 (the last trading day in our fiscal 2010 year) closing price of
our common stock of $0.92.
|
Option Awards
|
Stock Awards
|
|||||||||||||||
Name
|
Number of
Shares Acquired
on Exercise (#)
|
Value
Realized on
Exercise ($)
|
Number of
Shares
Acquired on
Vesting (#)
|
Value
Realized on
Vesting ($)
|
||||||||||||
Thomas
J. Lynch
|
- | - | 50,000 | 73,625 |
(1)
|
|||||||||||
Linda
LoRe
|
- | - | 100,000 | 156,000 |
(2)
|
|||||||||||
Thomas
Rende
|
- | - | - | - |
(1)
|
For
each share vested, the value realized on vesting represents the average of
the average of the high and low trading prices of our common stock on the
trading days prior to and after January 2, 2010, the vesting date (a
non-trading day) of $1.4725, multiplied by the number of shares acquired
on vesting.
|
(2)
|
For
each share vested, the value realized on vesting represents the closing
price of our common stock of $1.56 on December 31, 2009, the vesting date,
multiplied by the number of shares acquired on
vesting.
|
|
·
|
base
salary through the date of death or
disability;
|
|
·
|
any
non-equity incentive compensation that would have become payable for the
year in which the employment was terminated, pro-rated for the number of
months worked during the fiscal year of
termination;
|
|
·
|
all
valid business expense reimbursements;
and
|
|
·
|
all
accrued but unused vacation pay.
|
|
·
|
base
salary through the end of the employment term (January 2,
2014);
|
|
·
|
the
sum of $450,000;
|
|
·
|
any
non-equity incentive compensation that would have become payable for the
year in which the employment was terminated, pro-rated for the number of
months worked during the fiscal year of
termination;
|
|
·
|
life
and disability insurance benefits through the end of the employment
term;
|
|
·
|
company-paid
continuation of medical coverage for one year after the end of the
term;
|
|
·
|
all
valid business expense reimbursements;
and
|
|
·
|
all
accrued but unused vacation pay.
|
|
·
|
base
salary through the date of death or
disability;
|
|
·
|
any
non-equity incentive compensation that would have become payable for the
year in which the employment was terminated, pro-rated for the number of
months worked during the fiscal year of
termination;
|
|
·
|
all
valid business expense reimbursements;
and
|
|
·
|
all
accrued but unused vacation pay.
|
|
·
|
base
salary through the end of the employment term (June 1,
2013);
|
|
·
|
the
sum of $250,000;
|
|
·
|
any
non-equity incentive compensation that would have become payable for the
year in which the employment was terminated, pro-rated for the number of
months worked during the fiscal year of
termination;
|
|
·
|
life
and disability insurance benefits through the end of the employment
term;
|
|
·
|
company-paid
continuation of medical coverage for one year after the end of the
term;
|
|
·
|
all
valid business expense reimbursements;
and
|
|
·
|
all
accrued but unused vacation pay.
|
Name
|
Benefits
|
Change in
Control(1)
|
Death or
Disability
|
Involuntary
Termination
Without Cause
or
Resignation for
Good Reason
|
||||||||||
Thomas
J. Lynch
|
Base
Salary
|
$ | - | $ | - | $ | 1,845,000 | |||||||
Severance
|
- | - | 450,000 | |||||||||||
Restricted
Stock(2)
|
- | - | 92,000 | |||||||||||
Accelerated
Vesting of Stock Options(3)
|
- | - | 64,800 | |||||||||||
Medical
Insurance
|
- | - | 76,940 | |||||||||||
Disability
Insurance
|
- | - | 3,630 | |||||||||||
Life
Insurance
|
- | - | - | |||||||||||
Accrued
Vacation Pay
|
- | 47,077 | 47,077 | |||||||||||
Total
|
$ | - | $ | 47,077 | $ | 2,579,447 | ||||||||
Linda
LoRe(4)
|
Severance
|
$ | 1,137,500 | $ | - | $ | 812,500 | |||||||
Restricted
Stock(2)
|
92,000 | - | - | |||||||||||
Medical
Insurance
|
25,647 | - | 25,647 | |||||||||||
Accrued
Vacation Pay
|
292,747 | 292,747 | 292,747 | |||||||||||
Total
|
$ | 1,547,894 | $ | 292,747 | $ | 1,130,894 | ||||||||
Thomas
Rende
|
Base
Salary
|
$ | - | $ | - | $ | 878,333 | |||||||
Severance
|
- | - | 250,000 | |||||||||||
Medical
Insurance
|
- | - | 65,542 | |||||||||||
Disability
Insurance
|
- | - | 2,448 | |||||||||||
Life
Insurance
|
- | - | 8,040 | |||||||||||
Accrued
Vacation Pay
|
- | 31,795 | 31,795 | |||||||||||
Total
|
$ | - | $ | 31,795 | $ | 1,236,158 |
(1)
|
The
employment agreements for Messrs. Lynch and Rende do not contain any
change in control provisions. Ms. LoRe’s employment agreement,
dated as of January 29, 2008, which expired on August 1, 2010, contained a
change in control provision. The compensation that would have
been payable to Ms. LoRe in connection with a change in control under her
expired employment agreement is set forth in the table
above.
|
(2)
|
The
value of restricted stock subject to accelerated vesting represents the
closing price of our common stock of $0.92 on July 30, 2010, the last
trading day of the year ended July 31, 2010, multiplied by the shares of
restricted stock subject to accelerated
vesting.
|
(3)
|
The
value of stock options subject to accelerated vesting represents the
closing price of our common stock of $0.92 on July 30, 2010 the last
trading day of the year ended July 31, 2010, less the option exercise
price of $0.38, multiplied by 120,000 shares underlying the portion of the
option subject to accelerated
vesting.
|
(4)
|
The
amounts reflected in the table above represent what would have been
payable to Ms. LoRe had her employment terminated as of July 31, 2010
under her employment agreement, dated as of January 29, 2008, which
expired on August 1, 2010. Therefore, such payments will not be
owed to her upon any future
termination.
|
Name
|
Fees Earned or
Paid in Cash
($)
|
Stock Awards
($)(1)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||
Peter
Cole(2)
|
38,000 | - | - | 38,000 | ||||||||||||
John
L. Eisel(3)
|
16,000 | 24,000 | - | 40,000 | ||||||||||||
William
F. Harley(4)
|
- | 32,000 | - | 32,000 | ||||||||||||
Michael
A. Salberg(5)
|
26,667 | - | - | 26,667 | ||||||||||||
Joel
M. Simon(6)
|
27,583 | 4,084 | - | 31,667 | ||||||||||||
Milton
J. Walters(7)
|
30,750 | 10,251 | - | 41,001 |
(1)
|
Represents
the dollar value of the compensation that the director elected to receive
in shares of our common stock in lieu of cash
compensation.
|
(2)
|
As
compensation for Mr. Cole’s services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Cole received cash
payments of $38,000.
|
(3)
|
As
compensation for Mr. Eisel’s services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Eisel received cash
payments of $16,000 and payments in common stock of 19,962 shares at a
total value of $24,000.
|
(4)
|
As
compensation for Mr. Harley’s services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Harley received
payments in common stock of 26,648 shares at a total value of
$32,000.
|
(5)
|
As
compensation for Mr. Salberg’s services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Salberg received
cash payments of $26,667. Mr. Salberg’s term as a director
ended on May 12, 2010.
|
(6)
|
As
compensation for Mr. Simon’s services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Simon received cash
payments of $27,583 and payments in common stock of 3,665 shares at a
total value of $4,084. Mr. Simon’s term as a director ended on
May 12, 2010.
|
(7)
|
As
compensation for Mr. Walters’ services as a non-employee director and for
his attendance at board and/or committee meetings, Mr. Walters received
cash payments of $30,750 and payments in common stock of 8,497 shares at a
total value of $10,251.
|
·
|
each
person or group (as that term is used in Section 13(d)(3) of the Exchange
Act) known by us to be the beneficial owner of more than 5% of our
outstanding shares of common stock on November 29,
2010;
|
·
|
each
of our named executive officers and directors;
and
|
·
|
all
of our named executive officers and directors, as a
group.
|
Beneficial Ownership of
Our Common Stock on
November 29, 2010
|
||||||||
Name and Address of
Beneficial Owner(1)
|
Number
of Shares
|
Percent of
Class
|
||||||
TTG
Apparel, LLC
287
Bowman Avenue
Purchase,
New York 10577
|
1,766,322 |
(2)
|
4.6 | % | ||||
Tokarz
Investments, LLC
287
Bowman Avenue
Purchase,
New York 10577
|
8,704,515 |
(2)(3)
|
22.5 | % | ||||
Fursa
Alternative Strategies LLC, on behalf of certain funds and accounts
affiliated with or managed by it or its affiliates
P.O.
Box 813
Amityville,
New York 11701
|
18,868,871 | (4) | 46.9 | % | ||||
Thomas
J. Lynch
|
860,000 | (5) | 2.2 | % | ||||
Peter
Cole
|
598,112 | (6) | 1.6 | % | ||||
Thomas
Rende
|
436,720 | (7) | 1.1 | % | ||||
Linda
LoRe
|
875,249 | (8) | 2.2 | % | ||||
John
L. Eisel
|
135,024 | (9) | * |
Beneficial Ownership of
Our Common Stock on
November 29, 2010
|
||||||||
Name and Address of
Beneficial Owner(1)
|
Number
of Shares
|
Percent of
Class
|
||||||
William
F. Harley
Fursa
Alternative Strategies LLC
P.O.
Box 813
Amityville,
New York 11701
|
130,389 |
(10)
|
* | |||||
Milton
J. Walters
|
105,487 |
(11)
|
* | |||||
All
directors and executive officers as a group (7
individuals)
|
3,140,981 |
(12)
|
7.9 | % |
*
|
Less
than 1%.
|
(1)
|
Unless
otherwise noted, the business address of each of Thomas J. Lynch, Linda
LoRe, Peter Cole, Thomas Rende, John L. Eisel and Milton J. Walters is c/o
Frederick’s of Hollywood Group Inc., 6255 Sunset Boulevard, Hollywood,
California 90028.
|
(2)
|
According
to a Schedule 13D, dated January 28, 2008, and filed with the SEC on
February 5, 2008, Michael T. Tokarz is the sole controlling person and
manager of each of TTG Apparel, LLC and Tokarz Investments,
LLC.
|
(3)
|
Includes
317,538 shares of common stock issuable upon exercise of currently
exercisable warrants.
|
(4)
|
Represents
(a) 17,051,333 shares of common stock and (b) 1,817,538 shares of common
stock issuable upon exercise of currently exercisable
warrants. Of these securities, the following securities are
subject to a Pledge Agreement between Fursa Master Global Event Driven
Fund LP and Scotia Capital (USA) Inc. (“Pledge Agreement”): (i) 11,359,292
shares of common stock and (ii) 1,152,181 shares of common stock issuable
upon exercise of currently exercisable
warrants.
|
(5)
|
Includes
(a) currently exercisable options to purchase 240,000 shares of common
stock, (b) options to purchase 120,000 shares that become exercisable
within 60 days of November 29, 2010 and (c) 250,000 shares of restricted
stock, of which 50,000 shares are vested and 50,000 shares will vest on
each January 2, 2011, 2012, 2013 and 2014. Excludes options to
purchase 600,000 shares of common stock that are not exercisable within 60
days of November 29, 2010.
|
(6)
|
Includes
(a) 70,000 shares of common stock held by Performance Enhancement
Partners, LLC and (b) currently exercisable options to purchase 162,500
shares of common stock granted to Performance Enhancement Partners,
LLC. Peter Cole, as sole member of Performance Enhancement
Partners, has voting and dispositive power over these
shares.
|
(7)
|
Includes
(a) currently exercisable options to purchase 176,250 shares of common
stock, (b) 157,644 shares of common stock held jointly with Mr. Rende’s
spouse, (c) 1,650 shares of common stock owned by Mr. Rende’s spouse and
(d) 100,000 shares of restricted stock, of which 25,000 shares will vest
on each June 1, 2011 and 2012 and 50,000 shares will vest on June 1, 2013.
Excludes options to purchase 115,000 shares of common stock that are
not exercisable within 60 days of November 29,
2010.
|
(8)
|
Includes
(a) currently exercisable options to purchase 500,249 shares of common
stock, (b) options to purchase 25,000 shares that become exercisable
within 60 days of November 29, 2010 and (c) 200,000 shares of restricted
stock, of which 100,000 shares are vested and 50,000 shares vest on each
of December 31, 2010 and 2011. Excludes options to purchase
60,113 shares of common stock that are not exercisable within 60 days of
November 29, 2010.
|
(9)
|
Includes
currently exercisable options to purchase 6,000 shares of common
stock.
|
(10)
|
As
Chief Investment Officer of Fursa, William F. Harley exercises voting
and dispositive power over shares beneficially owned by certain funds and
accounts affiliated with, managed by, or over which Fursa or any of its
affiliates exercises investment authority, including, without limitation,
with respect to voting and dispositive rights, described in Footnote 4
above. Mr. Harley disclaims beneficial ownership of the shares described
in Footnote 4 above except to the extent of his pecuniary interest
therein. Accordingly, such shares are not included in Mr.
Harley’s beneficial ownership.
|
(11)
|
Includes
(a) 50,290 shares of common stock held by Sagebrush Group, Inc. and (b)
currently exercisable options to purchase 26,718 shares of common
stock. Excludes options to purchase 4,452 shares of common
stock that are not exercisable within 60 days of November 29,
2010. Milton Walters, as the sole shareholder of Sagebrush
Group, Inc., has voting and dispositive power over the shares held by
Sagebrush Group, Inc.
|
(12)
|
Includes
an aggregate of 1,256,717 shares of common stock that Thomas J. Lynch,
Peter Cole, Thomas Rende, Linda LoRe, John L. Eisel and Milton J. Walters
have the right to acquire upon exercise of outstanding options that are
exercisable within 60 days of November 29,
2010.
|
Plan Category
|
Number of Shares to be
Issued Upon Exercise of
Outstanding Options,
Warrants and Rights
|
Weighted-Average
Exercise Price of
Outstanding Options,
Warrants and Rights
|
Number of Shares
Remaining Available for
Future Issuance Under
Equity Compensation
Plans
|
|||||||||
Plans
approved by shareholders
|
||||||||||||
1988
Non-Qualified Stock Option Plan
|
732,500 | $ | 0.96 | 100,833 | ||||||||
2000
Performance Equity Plan
|
681,750 |
(1)
|
$ | 2.47 | 452,876 |
(2)
|
||||||
2003
Employee Equity Incentive Plan
|
975,974 | $ | 2.38 | – | ||||||||
January
2008 Warrants(3)
|
635,076 | $ | 3.31 | – | ||||||||
Plans
not approved by shareholders
|
||||||||||||
March
2010 Warrants(4)
|
2,543,760 | $ | 1.41 | – | ||||||||
May
2010 Warrants(5)
|
1,500,000 | $ | 2.33 | – | ||||||||
2010
Long-Term Incentive Equity Plan(6)
|
600,000 | $ | 0.78 | 3,400,000 | ||||||||
Total
|
7,669,060 | $ | 1.87 | 3,953,709 |
(1)
|
Includes
18,000 shares of common stock issuable upon exercise of options under our
2000 Performance Equity Plan granted to non-employee directors pursuant to
our Non-Employee Director Compensation
Plan.
|
(2)
|
Our
Non-Employee Director Compensation Plan provides that each non-employee
director may elect to receive his or her annual stipend and meeting fees
in cash and/or shares of our common stock under our 2000 Performance
Equity Plan in such proportion as is determined by each non-employee
director. If a non-employee director elects to be paid in stock, either in
full or in part, the number of shares of common stock to be issued is
determined by dividing the dollar amount of the stipend and meeting fees
earned during the quarter (or a percentage thereof, if the non-employee
director elects to receive stock payment in part) by the last sale price
of our common stock on the last trading day of each calendar quarter in
which the fees were earned. As of July 31, 2010, an aggregate
of 264,748 shares of common stock have been issued to non-employee
directors.
|
(3)
|
On
January 28, 2008, as sole consideration for their commitments to act as
standby purchasers in connection with our $20 million rights offering, we
issued to Fursa and Tokarz Investments, LLC warrants to purchase an
aggregate of 596,592 shares of common stock, subject to
adjustment. Pursuant to the anti-dilution adjustment provisions
contained in the warrants, following the consummation of our private
placement to accredited investors on March 16, 2010 (the “Private
Placement”), the number of shares of common stock issuable upon exercise
of the warrants was increased from an aggregate of 596,592 shares to an
aggregate of 635,076 shares and the exercise price was decreased from
$3.52 per share to $3.31 per share. The warrants expire on
January 28, 2011.
|
(4)
|
In
connection with the consummation of the Private Placement, we issued
to the investors two-and-a-half year Series A warrants to purchase up to
an aggregate of 1,162,820 shares of common stock at an exercise price of
$1.25 per share, and five-year Series B warrants to purchase up to an
aggregate of 1,162,820 shares of common stock at an exercise price of
$1.55 per share. In addition, we issued to Avalon Securities Ltd. and its
designees, who acted as placement agent in the transaction, warrants to
purchase an aggregate of 218,030 shares of common stock at an exercise
price of $1.21 per share. Except for the exercise price, these
warrants are identical to the Series B warrants issued to investors in the
Private Placement.
|
(5)
|
On
May 18, 2010, in connection with the consummation of the transactions
contemplated by the Debt Exchange and Preferred Stock Conversion
Agreement, dated as of February 1, 2010, with accounts and funds managed
by and/or affiliated with Fursa, we issued to Fursa three, five and
seven-year warrants, each to purchase 500,000 shares of common stock (for
an aggregate of 1,500,000 shares of common stock) at exercise prices of
$2.00, $2.33 and $2.66 per share,
respectively.
|
(6)
|
On June 29, 2010, our
board of directors adopted the 2010
Long-Term Incentive Equity Plan (including an Incentive Stock Option
Plan). This plan is subject to shareholder approval, which we
are seeking to obtain at our next scheduled annual
shareholders meeting. 4,000,000 shares of
common stock are authorized under the 2010 Long-Term Incentive Equity Plan
for the issuance of qualified and non-qualified stock options and other
stock-based awards to eligible participants. Options granted
under the 2010 Long-Term Incentive Plan are not subject to a uniform
vesting schedule. On June 29, 2010, we granted options to
purchase 600,000 shares of common stock under the 2010 Long-Term Incentive
Equity Plan to our Chief Executive Officer at an exercise price of
$0.78 per share, which vest as
follows: 150,000
shares vest on January 2, 2012, 200,000 shares vest on January 2, 2013 and
250,000 shares vest on January 2, 2014. These options were
outstanding as of July 31,
2010.
|
Years Ended,
|
||||||||
July 31, 2010
|
July 25, 2009
|
|||||||
Audit
Fees(1)
|
$ | 387,000 | $ | 415,000 | ||||
Audit
Related Fees(2)
|
42,000 | 21,000 | ||||||
Tax
Fees(3)
|
108,000 | 115,000 | ||||||
$ | 537,000 | $ | 551,000 |
(1)
|
Represents
the aggregate fees billed for professional services rendered in connection
with the audit of our consolidated financial statements and the review of
the consolidated financial statements included in our Quarterly Reports on
Form 10-Q.
|
(2)
|
Represents
the aggregate fees billed in connection with the reviews of various SEC
filings and employee benefit plan
audits.
|
(3)
|
Represents
the aggregate fees billed for professional services rendered for tax
compliance, tax advice and tax
planning.
|
EXHIBIT
NUMBER
|
EXHIBIT
|
METHOD OF FILING
|
||
31.1
|
Certification
by Chief Executive Officer
|
Filed
herewith
|
||
31.2
|
Certification
by Principal Financial and Accounting Officer
|
Filed
herewith
|
||
32
|
Section
1350 Certification
|
Filed
herewith
|
November
29, 2010
|
FREDERICK’S
OF HOLLYWOOD GROUP INC.
|
||
By:
|
/s/ THOMAS J. LYNCH
|
||
Thomas
J. Lynch
|
|||
Chairman
and Chief Executive Officer
|
|||
(Principal
Executive Officer)
|
|||
By:
|
/s/ THOMAS RENDE
|
||
Thomas
Rende
|
|||
Chief
Financial Officer
|
|||
(Principal
Financial and Accounting Officer)
|